Remission of the nephrotic syndrome in renal amyloidosis.
D000328:Adult; D000682:Amyloid / Q000032:analysis / Q000378:metabolism; D000686:Amyloidosis / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001706:Biopsy; D001987:Bronchiectasis / Q000150:complications; D002908:Chronic Disease; D004697:Endocarditis, Bacterial / Q000150:complications; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications; D006651:Histocytochemistry; D006801:Humans; D007674:Kidney Diseases; D007678:Kidney Glomerulus / Q000032:analysis; D008099:Liver / Q000032:analysis; D008169:Lung Abscess / Q000150:complications; D008297:Male; D009404:Nephrotic Syndrome; D011507:Proteinuria; D013997:Time Factors; D014261:Tricuspid Valve; D014397:Tuberculosis, Pulmonary / Q000150:complications
D000682:Amyloid; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents